The Pharming Group offers novel platforms for the production of protein therapeutics, as well as processes for the purification and formulation. The company’s best known product is Ruconest, a human C1 inhibitor. Human C1 inhibitor is a protein involved in the regulation of the complement and contact pathways of the immune system. Pharming Group N.V. is headquartered in Leiden, the Netherlands.